Specifically, we demonstrated that hDPSCs significantly improved cognitive decline and intracranial microenvironment in AD mice and that the beneficial effects were largely dependent on AKT/GSK3β-mediated Nrf2 activation and nuclear accumulation. This evidence concerns the gene GSK3B and Mental deterioration.